Presentation

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Presenter: Usman Baber

September 26, 2019

REGISTER for free or LOG IN to view this content

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Coronary

Presentation

TCT 2019

Up Next

Presentation

Why SEB Should Be Safer: Insights From Preclinical Study

Presenter: Aloke Finn

September 26, 2019

More slides +

Presentation

Predictions for a Changing Future in AS Management: Revised Guidelines, Expanded TAVR Indications, Shifting Referral Practices, and Earlier Treatment Decisions

Presenter: Philippe Genereux

September 26, 2019

Presentation

First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results

Presenter: Alexandre Abizaid

September 26, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.